Off the wire
• Commentary: Anti-invasion wall becomes bridge of love  • Netanyahu to continue heading Israel's ruling party  • Council of Europe honors Greek civil organization for helping migrants  • Kerry says implementation of Iranian nuke deal likely within coming days  • Spanish stock market rises 0.21 pct, closes at 8,934 points  • FIFA presidential hopefuls seek sub-regional chief's votes  • LME base metals increase mostly on Wednesday  • Azerbaijani president meets with U.S. National Security Council official over cooperation  • Biomass burning may play larger role in climate change: study  • SW China reports H5N1 case  
You are here: 　 Home

Canada announces support for establishing new stem cell research center

Xinhua, January 14, 2016 Adjust font size:

Canadian Prime Minister Justin Trudeau on Wednesday announced that the federal government of Canada will fund a new center for stem cell therapy in Toronto, capital of Ontario.

The prime minister made the announcement at Toronto-based MaRS, a non-profit corporation that brings together educators, researchers, social scientists, entrepreneurs and business experts in one setting.

"We must do more to prevent and treat disease in this country," said Trudeau, who is visiting Toronto in the day. He described regenerative medicine as "the future," and a branch of medicine that "Canada and Ontario are quite good at."

Regenerative medicine has shown promise in treating and preventing diseases, including using stem cells to repair and replace cells damaged by cancer, heart conditions and other medical disorders, according to a press release from Prime Minister Justin Trudeau's Office.

The Centre of Commercialization of Regenerative Medicine (CCRM) will receive 20 million Canadian dollars (about 14 million U.S. dollars) to establish and operate a new Centre for Advanced Therapeutic Cell Technologies.

The new center, which is called as an international hub in the field, will be the first to use a collaborative approach between publicly funded research institutions and the private sector, to solve cell therapy manufacturing challenges. It will cost a total of 43.8 million Canadian dollars, or 31 million U.S. dollars, with the balance to be covered by industry partners.

The projected facility will be finished by the end of 2018.

Trudeau will meet with Toronto Mayor John Tory at city hall later Wednesday, according to the Office of the Prime Minister. Endit